Literature DB >> 17005767

Prospective comparison of secretin-stimulated magnetic resonance cholangiopancreatography with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III.

Stephen P Pereira1, Alice Gillams, Spiros N Sgouros, George J M Webster, Adrian R W Hatfield.   

Abstract

BACKGROUND: In sphincter of Oddi dysfunction (SOD), sphincter of Oddi manometry (SOM) predicts the response to sphincterotomy, but is invasive and associated with complications. AIM: To evaluate the role of secretin-stimulated magnetic resonance cholangiopancreatography (ss-MRCP) in predicting the results of SOM in patients with suspected type II or III SOD.
METHODS: MRCP was performed at baseline and at 1, 3, 5 and 7 min after intravenous secretin. SOD was diagnosed when the mean basal sphincter pressure at SOM was >40 mm Hg. Long-term outcome after SOM, with or without endoscopic sphincterotomy, was assessed using an 11-point (0-10) Likert scale.
RESULTS: Of 47 patients (male/female 9/38; mean age 46 years; range 27-69 years) referred for SOM, 27 (57%) had SOD and underwent biliary and/or pancreatic sphincterotomy. ss-MRCP was abnormal in 10/16 (63%) type II and 0/11 type III SOD cases. The diagnostic accuracy of ss-MRCP for SOD types II and III was 73% and 46%, respectively. During a mean follow-up of 31.6 (range 17-44) months, patients with normal SOM and SOD type II experienced a significant reduction in symptoms (mean Likert score 8 vs 4; p = 0.03, and 9 vs 1.6; p = 0.0002, respectively), whereas in patients with SOD type III, there was no improvement in pain scores. All patients with SOD and an abnormal ss-MRCP (n = 12) reported long-term symptom improvement (mean Likert score 9.2 v 1.2, p<0.001).
CONCLUSIONS: ss-MRCP is insensitive in predicting abnormal manometry in patients with suspected type III SOD, but is useful in selecting patients with suspected SOD II who are most likely to benefit from endotherapy.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17005767      PMCID: PMC1954855          DOI: 10.1136/gut.2006.099267

Source DB:  PubMed          Journal:  Gut        ISSN: 0017-5749            Impact factor:   23.059


  36 in total

1.  ASGE guidelines for clinical application. The role of ERCP in diseases of the biliary tract and pancreas. American Society for Gastrointestinal Endoscopy.

Authors: 
Journal:  Gastrointest Endosc       Date:  1999-12       Impact factor: 9.427

Review 2.  Regulation of cholangiocyte bicarbonate secretion.

Authors:  N Kanno; G LeSage; S Glaser; G Alpini
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2001-09       Impact factor: 4.052

3.  ERCP is most dangerous for people who need it least.

Authors:  P B Cotton
Journal:  Gastrointest Endosc       Date:  2001-10       Impact factor: 9.427

4.  Use of (99m)Tc-DISIDA biliary scanning with morphine provocation for the detection of elevated sphincter of Oddi basal pressure.

Authors:  P D Thomas; J G Turner; B R Dobbs; M J Burt; B A Chapman
Journal:  Gut       Date:  2000-06       Impact factor: 23.059

5.  Frequency of abnormal pancreatic and biliary sphincter manometry compared with clinical suspicion of sphincter of Oddi dysfunction.

Authors:  D Eversman; E L Fogel; M Rusche; S Sherman; G A Lehman
Journal:  Gastrointest Endosc       Date:  1999-11       Impact factor: 9.427

6.  Comparison of sphincter of Oddi manometry, fatty meal sonography, and hepatobiliary scintigraphy in the diagnosis of sphincter of Oddi dysfunction.

Authors:  M L Rosenblatt; M F Catalano; E Alcocer; J E Geenen
Journal:  Gastrointest Endosc       Date:  2001-12       Impact factor: 9.427

Review 7.  MR imaging of the pancreas: a pictorial tour.

Authors:  Celso Matos; Olivier Cappeliez; Catherine Winant; Emmanuel Coppens; Jacques Devière; Thierry Metens
Journal:  Radiographics       Date:  2002 Jan-Feb       Impact factor: 5.333

8.  Risk factors for post-ERCP pancreatitis: a prospective, multicenter study.

Authors:  M L Freeman; J A DiSario; D B Nelson; M B Fennerty; J G Lee; D J Bjorkman; C S Overby; J Aas; M E Ryan; G S Bochna; M J Shaw; H W Snady; R V Erickson; J P Moore; J P Roel
Journal:  Gastrointest Endosc       Date:  2001-10       Impact factor: 9.427

9.  Endoscopic injection of botulinum toxin in patients with recurrent acute pancreatitis due to pancreatic sphincter of Oddi dysfunction.

Authors:  T Wehrmann; T H Schmitt; A Arndt; B Lembcke; W F Caspary; H Seifert
Journal:  Aliment Pharmacol Ther       Date:  2000-11       Impact factor: 8.171

10.  Manometry based randomised trial of endoscopic sphincterotomy for sphincter of Oddi dysfunction.

Authors:  J Toouli; I C Roberts-Thomson; J Kellow; J Dowsett; G T Saccone; P Evans; P Jeans; M Cox; P Anderson; C Worthley; Y Chan; N Shanks; A Craig
Journal:  Gut       Date:  2000-01       Impact factor: 23.059

View more
  15 in total

1.  Secretin-Enhanced MRCP: How and Why-AJR Expert Panel Narrative Review.

Authors:  Jordan Swensson; Atif Zaheer; Darwin Conwell; Kumar Sandrasegaran; Riccardo Manfredi; Temel Tirkes
Journal:  AJR Am J Roentgenol       Date:  2021-03-11       Impact factor: 3.959

Review 2.  Prospective comparison of secretin-stimulated MRCP with manometry in the diagnosis of sphincter of Oddi dysfunction types II and III.

Authors:  John Baillie; James Kimberly
Journal:  Gut       Date:  2007-06       Impact factor: 23.059

3.  Revision of anastomotic stenosis after pancreatic head resection for chronic pancreatitis: is it futile?

Authors:  Katherine A Morgan; Bennett B Fontenot; Norman R Harvey; David B Adams
Journal:  HPB (Oxford)       Date:  2010-04       Impact factor: 3.647

Review 4.  Functional Pancreatic Sphincter Dysfunction in Children: Recommendations for Diagnosis and Management.

Authors:  Tom K Lin; Douglas S Fishman; Matthew J Giefer; Quin Y Liu; David Troendle; Steven Werlin; Mark E Lowe; Aliye Uc
Journal:  J Pediatr Gastroenterol Nutr       Date:  2019-12       Impact factor: 2.839

5.  The effects of morphine-neostigmine and secretin provocation on pancreaticobiliary morphology in healthy subjects: a randomized, double-blind crossover study using serial MRCP.

Authors:  Abeed H Chowdhury; David J Humes; Susan E Pritchard; Luca Marciani; Penny A Gowland; John Simpson; Dileep N Lobo
Journal:  World J Surg       Date:  2011-09       Impact factor: 3.352

Review 6.  The diagnosis and management of Sphincter of Oddi dysfunction: a systematic review.

Authors:  Thomas C Hall; Ashley R Dennison; Giuseppe Garcea
Journal:  Langenbecks Arch Surg       Date:  2012-06-13       Impact factor: 3.445

7.  Biliary and gallbladder dyskinesia.

Authors:  Josh George; John Baillie
Journal:  Curr Treat Options Gastroenterol       Date:  2007-08

Review 8.  Acute recurrent pancreatitis: Etiopathogenesis, diagnosis and treatment.

Authors:  Pier Alberto Testoni
Journal:  World J Gastroenterol       Date:  2014-12-07       Impact factor: 5.742

Review 9.  Pancreatic ductal system obstruction and acute recurrent pancreatitis.

Authors:  M Delhaye; C Matos; M Arvanitakis; J Deviere
Journal:  World J Gastroenterol       Date:  2008-02-21       Impact factor: 5.742

Review 10.  Early successes and late failures in the prevention of post endoscopic retrograde cholangiopancreatography.

Authors:  John G Lieb; Peter V Draganov
Journal:  World J Gastroenterol       Date:  2007-07-14       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.